Refile: BUZZ-Sartorius edges up after Q3 earnings beats

Sartorius AG

Yesterday 08:58

Adds missing index name in 5th bullet
** Shares in Sartorius SATG.DE rise 2.4% after the biopharma supplier reported better-than-expected Q3 revenue, adjusted EBITDA
** The German company posted quarterly revenue of €926 million ($1.04 billion), with adjusted EBITDA of €280 million, which both exceeded Vara consensus expectations of €899 million and €269 million respectively
** "Sartorius delivered a strong third quarter," Jefferies says
** The stock, which has gained a fifth in value since mid-September, tops Germany's midcap index .MDAXI
** Its French unit Stedim Biotech's  STDM.PA shares also rise about 2%, being the second-best performer on France's SBF120 .SBF120 index
** Sartorius AG preferential shares SATG_p.DE are up 4.2%
     
($1 = 0.8896 euros)

 (Reporting by Danny Callaghan)
 ((Danny.Callaghan@thomsonreuters.com))